The g®-1 gene encodes a zinc ®nger containing protein that is speci®cally expressed in T-lymphocytes and is a frequent target of proviral insertion in T-cell lymphoma provoked by infection with MoMuLV ± a non acute transforming retrovirus. Expression of a g®-1 transgene targeted to T-cells by the lck proximal promoter provokes a reduction of peripheral CD4 and CD8 positive T-cells but nevertheless weakly predisposes transgenic animals for the development of T-cell lymphoma. Forced coexpression of the serine/threonine kinase Pim-1 can partially restore normal T-cell numbers in double pim-1/g®-1 transgenic mice. Moreover, the combinatorial expression of Pim-1 and G®-1 leads to accelerated development of T-cell lymphoma with a mean latency period of 114 days. A similar accelerated rate of lymphoma development was observed when lck-g®-1 mice were crossed with mice that carry a L-myc gene targeted to be expressed at high levels in T-cells. The results show that g®-1 can act with low activity as a dominant oncogene when overexpressed but also demonstrate that it is most ecient only in the presence of a cooperative partner protein as for example Pim-1 or L-Myc. In addition, the results suggest that Pim-1 and G®-1 are acting synergistically in both T-cell lymphomagenesis and T-cell development.
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The g®-1 gene was ®rst discovered as a proviral insertion site in rat T-lymphoid cells selected after MoMuLV infection for IL-2 independence (Gilks et al., 1993) . The g®-1 gene encodes a nuclear zinc ®nger protein and functions as a site speci®c DNA binding transcriptional repressor (Grimes et al., 1996) . The expression of G®-1 is highest in thymocytes and testes (Gilks et al., 1993 but is barely detectable in peripheral T-cells, where it is upregulated after antigenic stimulation. Although the exact physiological role of this protein remains to be elucidated, it could be shown that G®-1 is able to confer a certain degree of IL-2 independence to cells that require IL-2 for continuous proliferation (Gilks et al., 1993 . In an attempt to identify cooperating partners for a given oncogene during the process of lymphomagenesis, transgenic mice bearing transcriptionally activated oncogenes such as the c-myc gene under the control of the immunoglobulin enhancer (Em) mice have been subjected to proviral tagging experiments with MoMuLV (van Lohuizen et al., 1989; , Haupt et al., 1991 . The analysis of the proviral insertions of the MoMuLV retroviral DNA revealed activation of genes as pim-1 or bmi-1 as potent cooperating partners for the c-myc gene in lymphomagenesis (van Lohuizen et al., 1989) . The pim-1 gene encodes a cytoplasmic protein kinase and was originally itself identi®ed as a frequent target of insertional activation by MoMuLV (Selten et al., 1985) . Transgenic mice with a pim-1 transgene targeted to be expressed exclusively in lymphoid cells by the immunoglobulin enhancer (Em) develop T-cell lymphoma but with a long latency period of about 7 ± 9 months and an incidence of about 10% (van Lohuizen et al., 1989) .
The ®nding that infection of Em c-myc transgenic mice with MoMuLV showed preferential integration of the proviral DNA in the pim-1 gene implicated an ecient collaboration between myc and the pim-1 gene which could subsequently also be veri®ed by creating Em myc/ Em pim-1 double transgenic mice with dierent myc genes , MoÈ roÈ y et al., 1991 . All myc/ pim bitransgenic mice showed a dramatic acceleration in lymphomagenesis compared to the single transgenic parent strains where the c-myc gene was more ecient than the N-or L-myc genes , MoÈ roÈ y et al., 1991 . These neoplasms were still of clonal or oligoclonal origin as indicated by the presence of distinct rearrangements on TCRb loci , MoÈ roÈ y et al., 1991 . This suggested that additional events i.e. additional activated oncogenes were required for the development of a fully malignant tumor. To search for these additional oncogenes that cooperate with both myc and pim-1 genes, a MoMuLV infection of Em L-myc/pim-1 bitransgenic animals was performed. In this experiment, infection with MoMuLV could still accelerate lymphomagenesis in Em L-myc/Em pim animals and in a high percentage of the tumors the pal-1/g®-1 locus was aected by retroviral integration resulting in high level expression of the g®-1 gene , Scheijen et al., 1997 . This ®nding and the evidence from other experiments using single Em pim and Em c-myc transgenic mice in MoMuLV targeting experiments (Scheijen et al., 1997) suggested that g®-1 is a dominant oncogene that can be activated by a transcriptional upregulation similar to the myc or pim-1 genes. However, direct evidence that the g®-1 gene can act as a dominant transforming oncogene is lacking. To test whether g®-1 has such an activity after transcriptional activation we have generated transgenic mice that constitutively express high levels of g®-1 in the T-cell lineage by using the proximal lck promoter. We have described elsewhere that ± unexpectedly ± thymocyte numbers are low in lck-g®-1 transgenic mice and that the overexpression of the g®-1 gene causes a developmental block of early T-cell development at the DN to DP transition leading to a loss of thymic cellularity (Schmidt et al., submitted) . Here we show that lckg®-1 transgenic mice also have low numbers of mature CD4 and CD8 bearing T-cells in peripheral lymphoid organs which is very probably a direct consequence of the blocked DN to DP transition in the thymus provoked by overabundance of G®-1. Nevertheless, we ®nd that lck-g®-1 animals are by themselves weakly predisposed for lymphomagenesis and observe that coexpression of a transcriptionally deregulated pim-1 gene can restore the numbers of mature T-cells in lymph nodes and spleen in double transgenic mice. In addition, after a latency period of 30 ± 40 weeks, almost all double lck-g®-1/Em pim-1 and, similarly, lck-g®-1/ Em L-myc transgenic mice succumb to T-cell lymphoma which directly demonstrates the potential of G®-1 as a dominant oncogene and its ability to synergize with both myc and pim genes.
Results
Overexpression of Pim-1 restores relative numbers of mature T-cells in peripheral lymphoid organs of lck-g®-1 transgenic mice Transgenic mice that carry a g®-1 gene under the control of the lck proximal promoter have been generated and express, as already described, high levels of the transgene in thymocytes (Schmidt et al., submitted) . Here, the expression of transgenic g®-1 mRNA in peripheral mesenterial lymph nodes is documented in Figure 1 for the transgenic lines 124 and 223. To demonstrate that the transgenic construct can direct G®-1 protein expression speci®cally in peripheral T-cells, lymph nodes from transgenic mice and normal controls were prepared and cells bearing CD4 and CD8 surface markers were isolated using anti CD4 and anti CD8 antibodies coupled to magnetic beads (MACSelect, Miltenyi). The selected cells were checked by¯ow cytometry to be 498% CD4 or CD8 positive (not shown) and protein extracts were analysed by Western blotting. Using anity puri®ed anti G®-1 antibodies (Schmidt et al., submitted) we were able to detect high levels of G®-1 protein in cells derived from transgenic mice whereas in normal controls G®-1 was not present at appreciable levels ( Figure 1c ) indicating the functionality of the lck-g®-1 transgene in peripheral T-cells.
Lck-g®-1 animals from three dierent lines (lck-g®-1 124, lck-g®-1 223 and lck-g®-1 403) were crossbred with Em pim-1 transgenic mice and the resulting g®-1/ pim-1 double transgenic animals were identi®ed by analysing the DNA from tail tip biopsies as described . While Em pim-1 transgenic mice show no abnormalities in the development of lymphoid cells and have structurally intact lymphoid organs (van Lohuizen et al., 1989) single lck-g®-1 transgenic mice have much smaller thymi due to a severe loss of thymic cellularity as described (Schmidt et al., submitted) . This loss of thymic cellularity correlated with a loss of mature CD4 and CD8 positive T-cells in lymph nodes (Figure 2a, b) and in the spleen of lck-g®-1 transgenics (not shown). However, in the presence of the Em pim-1 transgene this loss of peripheral T-cells seen in single lck-g®-1 mice was almost completely reversed to the normal situation in g®-1/pim-1 double transgenics as shown for animals from a crossing with the g®-1 transgenic line 124 (Figure 2a,b) . Similar results were obtained in crossings between Em pim-1 mice with the other two lck-g®-1 lines 223 and 403 (not shown). This is in agreement with earlier observations that the coexpression of Pim-1 can partially restore thymic cellularity in g®-1/pim-1 double transgenics (Schmidt et al., submitted) . The data suggest that the Pim-1 overexpression antagonizes the eect of G®-1, i.e. that Pim-1 can relieve the developmental block imposed by the overexpression of the g®-1 transgene in the pre T-cells and restores normal cell numbers in the thymus (Schmidt et al., submitted) and subsequently also in peripheral lymphoid organs as shown here (Figure 2 ).
G®-1 has a low oncogenic potential but cooperates eciently with Pim-1 or L-Myc in T-cell lymphomagenesis
A population of 28 lck-g®-1/Em pim-1 double transgenic mice resulting from a crossing of Em pim-1 animals and Figure 1 Transgenic g®-1 construct and lck-g®-1 transgene expression in lymph nodes. (a) Schematic representation of the construct used to generate lck-g®-1 transgenic mice and (b) detection of endogenous and transgenic G®-1 speci®c mRNA in lymph nodes. Note that the transgene speci®c mRNA has a bigger size than the endogenous g®-1 transcript due to the hGH part in the construct. (c) G®-1 protein levels in CD4 and CD8 single positive cells isolated from lymph nodes of animals representing the lck-g®-1 transgenic lines 124 and 223 in comparison to cells from control lymph nodes from non transgenic littermates pim-1 and gfi-1 in T-cell development and lymphomagenesis T Schmidt et al the three dierent lines of lck-g®-1 transgenics was monitored for a period of 35 weeks. Within this period, almost all animals (23 of 28, 82%, Table 1 ) succumbed to lymphoid neoplasia that were apparent by swelling of peripheral lymphoid organs or could be detected by short breath of the animals due to a tumor in the thymus that by its size aected normal breathing. In almost all cases thymus, lymph nodes and spleen were aected. Thirty-four single lck-g®-1 transgenic animals were observed over the same period of time. Although these animals were housed under the same conditions and were in the same genetic background as the lck-g®-1/Em pim-1 double transgenics only three tumors arose in this population (8.8%, (Table 1) . Histological analysis of thymi and lymph nodes derived from either normal or double transgenic lckg®-1/Em pim-1 mice before tumor onset did not reveal a distinct prelymphomatous phenotype that would be dierent from a normal thymus or a normal lymph node (Figures 3 and 4) . In g®-1/pim-1 animals, the separation of thymi in cortex and medulla is maintained (Figure 3a ,b) and a normal follicular structure can be observed in lymph nodes ( Figure  4a ,b,e,f). However, in some instances thymi from double lck-g®-1/Em pim-1 transgenic animals showed an enlarged cortex and only residual or absent medulla which could indicate early stages of tumor development (Figure 3c ). After manifestation of tumors within Figure 2 Relative numbers of T-cells from mesenterial lymph nodes are reduced in lck-g®-1 transgenic mice but are almost normal in g®-1/pim-1 double transgenics. (a) Representative FACS plots demonstrating the frequencies of CD4 and CD8 T-cells in lymph nodes from a normal mouse, a lck-g®-1 transgenic mouse of the line 124 and the line 223, from a single Em pim-1 transgenic mouse and from a double transgenic pim-1/g®-1 animal (resulting from a cross with mice from the lck-g®-1 line 124). (b) Frequencies of CD4 and CD8 positive cells from peripheral lymph nodes is given as an average percentage with respect to total lymphocytes counts as in (a). Values are given with standard deviation for several mice representing the two dierent transgenic lines (for lck-g®-1 124, n=6 and for lck-g®-1 223, n=5), normal control littermates (n=7) and lck-g®-1/Em pim-1 double transgenics resulting from a cross between Em pim-1 mice and animals from two dierent lck-g®-1 lines (Em pim-1/lck-g®-1 line 124, n=3, Em pim-1/lck-g®-1 line 223, n=2)
pim-1 and gfi-1 in T-cell development and lymphomagenesis T Schmidt et al the thymus of lck-g®-1/Em pim-1 transgenics the histological analysis showed a total loss of thymic architecture, i.e. the absence of cortex and medulla (Figure 3c,d ) and the occasional presence of encapsulated structures (Figure 3e ) suggesting that neoplastic lymphoid cells had replaced the entire organ. Lymph nodes from lck-g®-1 single transgenics still display a follicular structure but were smaller than nodes from normal controls (Figure 4a,c,d ) very probably due to the loss of T-cells described above (Figure 2 ). Lymph nodes from double g®-1/pim-1 transgenic mice with a tumor were drastically enlarged, had lost their follicular structure and were densely packed with lymphocytes (Figure 4g ,h) very probably of neoplastic origin. The presence of characteristic surface markers as CD4, CD8 and Thy 1.2 indicated that the tumors had emerged from the T-lymphoid lineage (Table 1) . Moreover, distinct rearrangements of the T-cell receptor gene b locus could be detected in tumors from both lck-g®-1 single and g®-1/pim-1 double transgenic mice (Table 1) by Southern blotting using a Jb2 probe as described (MoÈ roÈ y et al., 1990) con®rming their T-cell origin. In addition, this indicated the clonality of the tumors and suggested that they were indeed malignant lymphoid neoplasms.
The mean latency period for tumors to arise in lckg®-1/Em pim-1 double transgenics was 114 days, i.e. the rate of tumor development in these mice was clearly accelerated in comparison to single Em pim-1 animals that itself develop T-cell lymphoma at lower frequency ( Figure 5 and van Lohuizen et al., 1989) . With regard to the mean latency period and the incidence of lymphoma development, the lck-g®-1/Em pim-1 mice were almost identical to single Em pim-1 animals after MoMuLV infection (Figure 5a , see also van Lohuizen et al., 1989 and ZoÈ rnig et al., 1996) .
To test the capacity of G®-1 to cooperate with myc genes lck-g®-1 animals were crossbred with Em L-myc transgenics that are similar to the Em pim-1 mice weakly predisposed to develop T-cell lymphoma (MoÈ roÈ y et al., 1990). A rescue of peripheral T-cell numbers similar to g®-1/pim-1 bitransgenics could not be observed in double L-myc/g®-1 transgenic animals (data not shown). However, among a population of 12 L-myc/g®-1 transgenic animals nine developed tumors within a mean latency period of 148 days (Figure 5b ) providing again direct evidence for a cooperative eect between a myc gene and the g®-1 gene. Based on rearrangements of the T-cell receptor b locus (Table 1) and on the presence of various T-cell speci®c surface markers all tumors that arose in Em L-myc/lck-g®-1 double transgenic mice tested were identi®ed as T-cell lymphoma of a monoclonal origin very similar to the neoplasms observed in g®-1/pim-1 animals (Table 1) . Cells from tumors were clearly larger in size compared to normal T-cells from thymus when analysed by FACS on their forwards angle light scatter (not shown) suggesting that the tumor cells are lymphoblasts.
These ®ndings directly demonstrate for the ®rst time an oncogenic potential for G®-1 as a consequence of overabundance and the ability of G®-1 to eciently cooperate with other oncogenes in lymphomagenesis. Further, the oncogenic activity of G®-1 appears similar and comparable to the activity of Pim-1 that itself has only a weak activity to predispose transgenic animals for the development of T-cell lymphoma (van Lohuizen et al., 1989) but unfolds a strong tumorigenic eect in cooperation with other oncogenes for example myc genes , MoÈ roÈ y et al., 1991 .
Discussion
With regard to numerous other experiments where it could be demonstrated that the g®-1 gene is a target of MoMuLV proviral integration , Berns et al., 1994 , Scheijen et al., 1997 , Gilks et al., 1993 our ®ndings documented here can be taken as formal proof that the g®-1 gene can act as a dominant oncogene. Activation of the g®-1 gene by transcrip- T  T  T  T  T  T  T  T  T  T  T  T  T  T  T  nd  T *Mouse found dead in cage with manifestation of a tumor in thymus, lymph nodes and spleen. Characterization of tumors that arose in populations of Em pim-1/lck-g®-1 double transgenic mice, Em L-myc/lck-g®-1 double transgenics or single lck-g®-1 transgenic animals. The number of the respective mouse bearing the tumor is indicated as well as the transgenic lck-g®-1 line. The rearrangements of the T-cell receptor b locus were determined by Southern blot analysis of DNA directly prepared from tumor tissue using the Jb2 probe as described before (MoÈ roÈ y et al., 1990). Single cell suspensions from tumor samples were stained with directly labeled antibodies for Thy-1.2, B220, CD4 and CD8 surface markers according to standard procedures. The latency period after which a particular tumor was observed (DT) is given in days (d) tional upregulation provokes a low incidence of lymphomas (8.8%) over a long latency period (35 weeks) and is in this respect very similar to the pim-1 gene which itself is very frequently activated by proviral insertion after MoMuLV infection (Selten et al., 1985) but when overexpressed displays only mild tumorigenic eects (van Lohuizen et al., 1989) . While single g®-1 transgenic animals develop few tumors and only after a long latency period double lck-g®-1/Em pim-1 transgenic animals were now found to be strongly predisposed for the development of lymphoid neoplasms of clonal origin. The rate of tumor onset was clearly faster than in pim-1 and g®-1 single transgenics. It is noteworthy that the death rate in the double transgenic animals is very similar to the death rate observed in Em pim-1 transgenic mice infected with supF MoMuLV suggesting that the crossing of a constitutively expressed g®-1 allele into Em pim-1 animals can mimic the eect of MoMuLV infection of Em pim-1 mice. A high number of tumors that arise after MoMuLV infection of wild type mice show integration in myc or pim genes but rarely in the g®-1/pal-1 locus (Berns et al., 1994 , van Lohuizen et al., 1989 . This can be interpreted as an indication that the activation of the g®-1 gene by proviral integration alone is not sucient to induce T- With regard to the negative eect of constitutive G®-1 expression on pre T-cell proliferation in the thymus (Schmidt et al., submitted) it is conceivable that single MoMuLV integrations that activate only the g®-1 gene are rarely found in tumors because these cells would not have gained a proliferative advantage and hence would not be selected for in contrast to cells with integration in the myc or pim-1 genes. The low incidence of tumors in single lck-g®-1 transgenic animals supports this view. However, our data show also that coexpression of a suitable cooperating oncogene in this case the transcriptionally activated pim-1 gene the negative eects of G®-1 on T-cell development and proliferation can be neutralized. This was documented by the partial restoration of normal T-cell numbers in lymph nodes of lck-g®-1/Em pim-1 double transgenic mice. In this situation however, G®-1 behaves as a classical dominant oncogene and can cooperate with Pim-1 and provokes the rapid outgrowth of lymphoid neoplasms. It is unclear why G®-1 only unveils a strong oncogenic eect in the presence of overabundant Pim-1 but the ®ndings again support earlier speculations that in the course of tumor development induced by infection with MoMuLV the activation of g®-1 is very likely not the ®rst event that helps T-cells to be selected to originate a lymphoid tumor; rather g®-1 activation would represent a later event possibly associated with tumor progression and growth factor independence (Gilks et al., 1993 , Scheijen et al., 1997 .
Previous ®ndings pointed to a role of G®-1 in sustaining cellular proliferation , Grimes et al., 1996 . By contrast, single lck-g®-1 transgenic mice that would have been expected to support a similar phenotype consistent with the previous ®ndings with cultured cells show a block of pre T-cell proliferation and dierentiation leading to low numbers of T-cell precursors in the thymus (Schmidt et al., submitted) and as a direct consequence to reduced numbers of mature T-cells in the periphery (data shown here) which is hardly consistent with a prelymphomatous state. Strikingly, the block in early T-cell dierentiation due to high levels of G®-1 can be partially overcome by coexpression of Pim-1 in double transgenic mice leading to a partial rescue of thymic cellularity (Schmidt et al., submitted) . The consequence of this cooperative eect of Pim-1 and G®-1 is on one hand the repopulation of the peripheral lymphoid organs with almost normal numbers of mature CD4 and CD8 T-cells (data shown here) but also a high predisposition for the development of T-cell lymphoma. The molecular and biochemical basis for this synergism of Pim-1 and G®-1 remains to be fully elucidated and requires further investigation but the ®ndings documented here suggest a role of both proteins in the control of T-cell development and dierentiation very probably on complementary signaling pathways. Figure 4 Histological analysis of lymph nodes and tumors located within lymph nodes. Shown are cross sections through lymph nodes from normal control mice each at two dierent enlargements: shown are nodes from normal control animals (a, b), from lckg®-1 transgenic mice (c, d) from lck-g®-1/Em pim-1 double transgenic animals before tumor manifestation (e, f) and from a tumor that arose in a lck-g®-1/Em pim-1 double transgenic mouse (g, h). Enlargement was 32 fold (a, c, e, g) and 128 fold (b, d, f, h) pim-1 and gfi-1 in T-cell development and lymphomagenesis T Schmidt et al
Materials and methods

Transgenic mice
All transgenic mice used in this study were generated from ovae obtained from an F1 (C57/B166C3H) or a (C57/ B166DBA) background as described (Hogan et al., 1986) and transgenic lines were kept by crossbreeding with C57/ B16 animals. The lck-g®-1 transgenic mice analysed here represent the third generation obtained upon backcrossing the founder animals. The Em pim-1 and Em L-myc animals in this study stem from backcrosses with C57/B16 animals over a period of 8 years.
Molecular analyses and probes
Preparation of genomic DNA from tail tips and tumor samples was performed as previously described (Hogan et al., 1986) . DNA blotting procedures were performed as described elsewhere (Sambrook et al., 1989) . The Jb2 probe that was used to detect TCRb rearrangements is a 1.9 kb HindIII-BamHI fragment containing the Jb locus as described (MoÈ roÈ y et al., 1990) . For the genotyping of lck-g®-1 transgenic mice a 2.0 kb Asp 718/BamHI fragment from the murine g®-1 genomic locus was used in Southern blot analysis on tail tip derived DNA digested with BglII:
Histology
Tumor tissue or organs were ®xed in 4% paraformaldehyde or in Carnoy's solution (60% ethanol, 30% chloroform, 10% acetic acid), embedded in paran and sectioned using a cryomicrotome. Sections were stained with hematoxylin/eosin. 
